John P. Brancaccio is Director at SYNERGY PHARMACEUTICALS, INC. (SGYP). They have made 11 open-market trades across 7 companies since 2006, most recently 2026-07-21.
CIK 0001276551
10 open-market purchases totalling $144K since 2006, against 1 sale. Across 9 scored buys the stock is up 17.0% at ninety days, and 12.5 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 22% | 33% | 22% |
| Avg Move | -2.4% | +3.2% | +17.0% |
| Alpha | -16.4% | +2.1% | +12.5% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OKYO | BUY | 2023-09-15 | 2023-09-28 | $1.50 | $25K | -1.1% | -14.4% | -1.6% |
| CRDF | BUY | 2021-03-22 | 2021-03-22 | $10.95 | $33K | -11.2% | -22.1% | -27.9% |
| HEPA | BUY | 2020-12-02 | 2020-12-02 | $1.53 | $11K | +0.0% | +0.0% | +0.0% |
| CRDF | BUY | 2020-05-14 | 2020-05-18 | $1.43 | $10K | +28.0% | +38.9% | +193.3% |
| TROV | BUY | 2018-06-08 | 2018-06-13 | $0.80 | $8K | N/A | N/A | N/A |
| SGYP | BUY | 2017-05-26 | 2017-05-30 | $3.59 | $23K | +16.5% | +26.4% | -11.0% |
| SGYP | SELL | 2016-09-19 | 2016-09-21 | $5.76 | $15K | -1.4% | -6.5% | -11.7% |
| SGYP | BUY | 2014-06-03 | 2014-06-03 | $4.12 | $14K | -28.4% | -3.9% | -3.9% |
| CTRV | BUY | 2014-03-04 | 2014-03-07 | $1.49 | $7K | -24.7% | +4.0% | +4.0% |
| ACEL | BUY | 2007-10-19 | 2007-10-22 | $1.94 | $4K | -0.5% | +0.0% | +0.0% |
| ACEL | BUY | 2006-07-24 | 2006-07-24 | $2.05 | $8K | -0.5% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $173K |
Shares reported on the most recent Form 4, priced at the 2026-07-23 close. 1 holding could not be priced and is excluded from the total.